CLARIVATE PLC: Change of Directors or Key Officers, Financial Statements and Supporting Documents (Form 8-K)

Item 5.02 Departure of directors or certain officers; Election of directors; Appointment of certain officers; Compensatory provisions of certain agents


Moukhtar Ahmed, President, Scientific Segment of Clarivate plc (the “Company”) will leave its post, as of April 1, 2022. After this date, Mr. Ahmed will remain available on an advisory basis until October 1, 2022.

The Company’s press release dated January 10, 2022 announcing this change in management is attached hereto as Exhibit 99.1.


At January 7, 2022, the Company has entered into a separation agreement with Mr. Ahmed. The separation agreement includes the usual terms and conditions and provides that Mr. Ahmed is entitled to the following: (i) cash, consisting of severance pay and a prorated portion of his 2022 bonus, in a total amount of approximately $ 2,406,000 (converted from pounds (GBP) at the exchange rate on
January 7, 2022) payable a) a third party within 30 days October 1, 2022 and (b) the remaining two-thirds paid in four quarterly installments after October 1, 2022; and (ii) the accelerated acquisition of 28,591 unvested restricted stock units. In addition, the period during which the purchased stock options may be exercised will be extended to December 31, 2024.

The foregoing description of the agreement with Mr. Ahmed contained in this document does not purport to be complete and is qualified in its entirety by reference to the full text of its agreement, a copy of which will be filed as an attachment to the Company’s annual report on Form 10-K for the fiscal year ended. December 31, 2021.

Article 9.01. Financial statements and supporting documents

(d) Exhibitions

 No.      Description
 99.1       Press release issued by Clarivate Plc dated January 10, 2022.
 104      Cover page of this Current Report on Form 8-K formatted in Inline XBRL.

————————————————– ——————————

© Edgar online, source Previews

Comments are closed.